img

Global Klebsiella Pneumoniae Infection Drug Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 450 | Industry : Pharma & Healthcare

Publisher : GRD Survery | Format : PDF

Global Klebsiella Pneumoniae Infection Drug Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Klebsiella Pneumoniae Infection Drug market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Klebsiella Pneumoniae Infection Drug industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Klebsiella Pneumoniae Infection Drug market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Klebsiella Pneumoniae Infection Drug Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Klebsiella Pneumoniae Infection Drug market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Klebsiella Pneumoniae Infection Drug Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Klebsiella Pneumoniae Infection Drug industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
ATI-1503
CA-824
EBX-004
Others

Segmented by Application
Hospital
Clinic
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Shionogi & Co Ltd
Sarepta Therapeutics Inc
Phico Therapeutics Ltd
Pfizer Inc
Peptilogics Inc
Nosopharm SAS
Melinta Therapeutics Inc
Kyorin Pharmaceutical Co Ltd
Innovation Pharmaceuticals Inc
ImmunoClin Corp
FOB Synthesis Inc
F. Hoffmann-La Roche Ltd
Evaxion Biotech ApS
Debiopharm International SA
Appili Therapeutics
Acies Bio doo


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Klebsiella Pneumoniae Infection Drug Market Status and Forecast (2016-2027)
1.3.2 Global Klebsiella Pneumoniae Infection Drug Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Klebsiella Pneumoniae Infection Drug Supply by Company
2.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume by Company
2.2 Global Klebsiella Pneumoniae Infection Drug Sales Value by Company
2.3 Global Klebsiella Pneumoniae Infection Drug Price by Company
2.4 Klebsiella Pneumoniae Infection Drug Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Klebsiella Pneumoniae Infection Drug Market Status by Type
3.1 Klebsiella Pneumoniae Infection Drug Type Introduction
3.1.1 ATI-1503
3.1.2 CA-824
3.1.3 CC-1807
3.1.4 Cefiderocol
3.1.5 Debio-1454
3.1.6 EBX-004
3.1.7 Others
3.2 Global Klebsiella Pneumoniae Infection Drug Market by Type
3.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
3.2.2 Global Klebsiella Pneumoniae Infection Drug Sales Value by Type (2016-2021)
3.2.3 Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Klebsiella Pneumoniae Infection Drug Market Status by Application
4.1 Klebsiella Pneumoniae Infection Drug Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Klebsiella Pneumoniae Infection Drug Market by Application
4.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
4.2.2 Global Klebsiella Pneumoniae Infection Drug Sales Value by Application (2016-2021)
4.2.3 Global Klebsiella Pneumoniae Infection Drug Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Klebsiella Pneumoniae Infection Drug Market Status by Region
5.1 Global Klebsiella Pneumoniae Infection Drug Market by Region
5.1.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume by Region
5.1.2 Global Klebsiella Pneumoniae Infection Drug Sales Value by Region
5.2 North America Klebsiella Pneumoniae Infection Drug Market Status
5.3 Europe Klebsiella Pneumoniae Infection Drug Market Status
5.4 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Status
5.5 Central & South America Klebsiella Pneumoniae Infection Drug Market Status
5.6 Middle East & Africa Klebsiella Pneumoniae Infection Drug Market Status
6 North America Klebsiella Pneumoniae Infection Drug Market Status
6.1 North America Klebsiella Pneumoniae Infection Drug Market by Country
6.1.1 North America Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
6.1.2 North America Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Klebsiella Pneumoniae Infection Drug Market Status
7.1 Europe Klebsiella Pneumoniae Infection Drug Market by Country
7.1.1 Europe Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
7.1.2 Europe Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Klebsiella Pneumoniae Infection Drug Market Status
8.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Market by Country
8.1.1 Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Klebsiella Pneumoniae Infection Drug Market Status
9.1 Central & South America Klebsiella Pneumoniae Infection Drug Market by Country
9.1.1 Central & South America Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
9.1.2 Central & South America Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Klebsiella Pneumoniae Infection Drug Market Status
10.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Market by Country
10.1.1 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis
11.5 Klebsiella Pneumoniae Infection Drug Sales Channel and Distributors Analysis
11.5.1 Klebsiella Pneumoniae Infection Drug Sales Channel
11.5.2 Klebsiella Pneumoniae Infection Drug Distributors
11.6 Klebsiella Pneumoniae Infection Drug Downstream Major Buyers
12 Global Klebsiella Pneumoniae Infection Drug Market Forecast by Type and by Application
12.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Klebsiella Pneumoniae Infection Drug Forecast by Type
12.2.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Type
12.2.2 Global Klebsiella Pneumoniae Infection Drug Sales Value Forecast by Type
12.2.3 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Type
12.3 Global Klebsiella Pneumoniae Infection Drug Forecast by Application
12.3.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Application
12.3.2 Global Klebsiella Pneumoniae Infection Drug Sales Value Forecast by Application
12.3.3 Global Klebsiella Pneumoniae Infection Drug Price Forecast by Application
13 Global Klebsiella Pneumoniae Infection Drug Market Forecast by Region/Country
13.1 Global Klebsiella Pneumoniae Infection Drug Market Forecast by Region (2022-2027)
13.1.1 Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Klebsiella Pneumoniae Infection Drug Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Tetraphase Pharmaceuticals Inc
14.1.1 Company Information
14.1.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.1.3 Tetraphase Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Syntiron LLC
14.2.1 Company Information
14.2.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.2.3 Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Shionogi & Co Ltd
14.3.1 Company Information
14.3.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.3.3 Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Sarepta Therapeutics Inc
14.4.1 Company Information
14.4.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.4.3 Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Phico Therapeutics Ltd
14.5.1 Company Information
14.5.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.5.3 Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Pfizer Inc
14.6.1 Company Information
14.6.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.6.3 Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Peptilogics Inc
14.7.1 Company Information
14.7.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.7.3 Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Nosopharm SAS
14.8.1 Company Information
14.8.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.8.3 Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Melinta Therapeutics Inc
14.9.1 Company Information
14.9.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.9.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Kyorin Pharmaceutical Co Ltd
14.10.1 Company Information
14.10.2 Klebsiella Pneumoniae Infection Drug Product Introduction
14.10.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Innovation Pharmaceuticals Inc
14.12 ImmunoClin Corp
14.13 FOB Synthesis Inc
14.14 F. Hoffmann-La Roche Ltd
14.15 Evaxion Biotech ApS
14.16 Debiopharm International SA
14.17 Appili Therapeutics
14.18 Acies Bio doo
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Klebsiella Pneumoniae Infection Drug Sales Value and CAGR by Region (2016-2027)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume by Company (2019-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Company (2019-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Company (2019-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value and CAGR by Region (2016-2027)
Table Global Klebsiella Pneumoniae Infection Drug Price by Company (2019-2021)
Table Main Manufacturers Klebsiella Pneumoniae Infection Drug Product Location and Sales Area
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Company (2019-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Type (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sals Value Market Share by Type (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Price by Type (2016-2021)
Table North America Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Type (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2016-2021)
Table Central & South America Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
Table Central & South America Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume by Type (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Type (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Application (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Value Market Share by Application (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Price by Application (2016-2021)
Table North America Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Application (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2016-2021)
Table Central & South America Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
Table Central & South America Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume by Application (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Application (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume by Region (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Region (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Region (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Value Market Share by Region (2016-2021)
Table North America Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
Table North America Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Country (2016-2021)
Table Global Klebsiella Pneumoniae Infection Drug Sales Value by Region/Country (2016-2021)
Table North America Klebsiella Pneumoniae Infection Drug Value Market Share by Country (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Country (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
Table Europe Klebsiella Pneumoniae Infection Drug Value Market Share by Country (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
Table Asia Pacific Klebsiella Pneumoniae Infection Drug Value Market Share by Country (2016-2021)
Table Central & South America Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
Table Central & South America Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Country (2016-2021)
Table Central & South America Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
Table Central & South America Klebsiella Pneumoniae Infection Drug Value Market Share by Country (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume by Country (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Sales Value by Country (2016-2021)
Table Middle East & Africa Klebsiella Pneumoniae Infection Drug Value Market Share by Country (2016-2021)
Table Klebsiella Pneumoniae Infection Drug Raw Materials Key Suppliers List
Table Klebsiella Pneumoniae Infection Drug Distributors List
Table Klebsiella Pneumoniae Infection Drug Buyers List
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Type (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Forecast by Type (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Market Share Forecast by Type (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Price Forecast by Type (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Application (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Forecast by Type (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Forecast by Application (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Market Share Forecast by Application (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Price Forecast by Application (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Sales Volume Forecast by Region (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Forecast by Application (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Forecast by Region (2022-2027)
Table Global Klebsiella Pneumoniae Infection Drug Value Market Share Forecast by Region (2022-2027)
Table Tetraphase Pharmaceuticals Inc Company Information
Table Tetraphase Pharmaceuticals Inc Product Introduction
Table Global Klebsiella Pneumoniae Infection Drug Value Forecast by Region (2022-2027)
Table Syntiron LLC Company Information
Table Syntiron LLC Product Introduction
Table Syntiron LLC Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Shionogi & Co Ltd Company Information
Table Shionogi & Co Ltd Product Introduction
Table Shionogi & Co Ltd Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Sarepta Therapeutics Inc Company Information
Table Sarepta Therapeutics Inc Product Introduction
Table Sarepta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Phico Therapeutics Ltd Company Information
Table Phico Therapeutics Ltd Product Introduction
Table Phico Therapeutics Ltd Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Pfizer Inc Company Information
Table Pfizer Inc Product Introduction
Table Pfizer Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Peptilogics Inc Company Information
Table Peptilogics Inc Product Introduction
Table Peptilogics Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Nosopharm SAS Company Information
Table Nosopharm SAS Product Introduction
Table Nosopharm SAS Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Melinta Therapeutics Inc Company Information
Table Melinta Therapeutics Inc Product Introduction
Table Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Kyorin Pharmaceutical Co Ltd Company Information
Table Kyorin Pharmaceutical Co Ltd Product Introduction
Table Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Sales Volume, Price, Sales Value and Gross Margin (2019-2021)